Latest Recruitment News

Page 16 of 41
TrivarX has reported promising interim results from its US veteran-focused mental health trial using ECG technology, while progressing a strategic acquisition of novel brain tumor imaging IP to broaden its diagnostic portfolio.
Ada Torres
Ada Torres
31 Oct 2025
BauMart Holdings reports progress in AI-driven international recruitment and sustainable building materials development, alongside a $180,000 capital raise to support growth initiatives.
Victor Sage
Victor Sage
30 Oct 2025
Paradigm Biopharmaceuticals has initiated dosing in its pivotal Phase 3 trial for knee osteoarthritis pain, backed by a strong cash position and strategic portfolio expansion. The company targets accelerated recruitment and a mid-2026 interim analysis.
Ada Torres
Ada Torres
30 Oct 2025
Urbanise.com Limited reported a 12.4% revenue increase in Q1 FY2026, driven by its NAB partnership, while investing heavily in its Data and Payments Integration Services (DPIS) with expected cash outflows through FY2026.
Sophie Babbage
Sophie Babbage
30 Oct 2025
NeuroScientific Biopharmaceuticals has secured regulatory approval for initial patient treatments under its Special Access Program for StemSmart™ in Crohn’s disease, alongside key executive appointments and a manufacturing partnership to support upcoming clinical trials.
Ada Torres
Ada Torres
30 Oct 2025
Dalaroo Metals has broadened its gold footprint in Côte d’Ivoire with four new project acquisitions while completing initial exploration in Greenland’s critical minerals sector. A $1 million capital raise supports these strategic moves as leadership changes unfold.
Maxwell Dee
Maxwell Dee
30 Oct 2025
Kingston Resources reported a 10% revenue increase to $15.8 million in Q1 FY26, driven by higher gold and silver output and successful flotation plant commissioning. Underground mining preparations are advancing, setting the stage for a production ramp-up.
Maxwell Dee
Maxwell Dee
30 Oct 2025
Hiremii Limited reported a 6% revenue increase and an 18% rise in gross profit for Q1 FY26, driven by global job board integration and a successful capital raise to fuel its AI-powered recruitment platform.
Sophie Babbage
Sophie Babbage
30 Oct 2025
Resonance Health reports positive cash flow and significant progress in its clinical trials and Software-as-a-Medical Device business, setting the stage for growth in new international markets.
Victor Sage
Victor Sage
29 Oct 2025
Harvest Technology Group reported improved EBITDA and secured new customers across mining, defence, and border control sectors in Q1 FY2026, supported by $2.13 million raised through convertible notes and loans.
Sophie Babbage
Sophie Babbage
29 Oct 2025
Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.
Ada Torres
Ada Torres
29 Oct 2025
BlinkLab has completed its U.S. autism pilot study with strong diagnostic accuracy and expanded its pivotal FDA trial to seven leading research centers, positioning itself for regulatory submission in late 2026.
Ada Torres
Ada Torres
29 Oct 2025